---
schema_version: "secwatch.filing_event.v1"
accession: "0001708599-26-000040"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2026-06-24T20:10:12+00:00"
generated_at: "2026-06-24T20:11:27.849002+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Serina increases authorized common stock from 40M to 125M; equity plan expanded by 2M shares

## Summary
- Authorized common stock increased from 40,000,000 to 125,000,000 shares via filed certificate of amendment.
- 2024 Equity Incentive Plan share reserve raised by 2,000,000 shares to 5,210,478; evergreen start moved to FY2027.
- Stockholders approved all eight proposals at annual meeting, including director elections and share increase.

## SEC filing metadata
- accession: 0001708599-26-000040
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2026-06-24T20:10:12+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000170859926000040/0001708599-26-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000170859926000040/ser-20260617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001708599-26-000040
- JSON: https://secwatch.observer/filing/0001708599-26-000040.json
- Plain text: https://secwatch.observer/filing/0001708599-26-000040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.